JBS N.V. (JBS) is a Packaged Foods company in the Consumer Defensive sector, currently trading at $18.07. It has a SharesGrow Score of 62/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of JBS = $31.60 (+74.9% from the current price, the stock appears undervalued). Analyst consensus target is JBS = $19 (+3.8% upside).
Valuation: JBS trades at a trailing Price-to-Earnings (P/E) of 8.3 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.17.
Financials: revenue is $471.1B, +7.5%/yr average growth. Net income is $11.1B, growing at +305%/yr. Net profit margin is 2.4% (thin). Gross margin is 12.8% (-3.1 pp trend).
Balance sheet: total debt is $125.7B against $47.9B equity (Debt-to-Equity (D/E) ratio 2.63, leveraged). Current ratio is 1.6 (strong liquidity). Debt-to-assets is 50.6%. Total assets: $248.3B.
Analyst outlook: 3 / 3 analysts rate JBS as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 81/100 (Pass), Growth 83/100 (Pass), Past 75/100 (Partial), Health 33/100 (Fail), Moat 51/100 (Partial), Future 82/100 (Pass), Income 30/100 (Fail).
